Skip to main
ABSI

Absci Corp (ABSI) Stock Forecast & Price Target

Absci Corp (ABSI) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Absci Corp's innovative approach to biologic drug discovery, notably through its AI-powered synthetic biology platform, positions the company favorably in the therapeutics market with the potential for significant growth in the creation of novel biologics. The management's projection of a target hair growth of at least 40 hairs/cm² for ABS-201 is deemed highly competitive, with an increased rNPV to $1.6 billion indicating strong financial potential based on the forthcoming efficacy data from the MAD study. The heightened interest in ABS-201, illustrated by substantial consumer demand for in-office procedures, further underscores the anticipated positive trajectory of the company’s product pipeline and market positioning.

Bears say

The analysis indicates several risks that could hinder the performance of Absci Corp's stock, including challenges in partnerships, technology, and regulatory approvals, which are essential for the company's success in the competitive synthetic biology market. Additionally, the lack of strong standard of care in endo for non-hormonal treatment options, coupled with a high treatment burden leading patients to seek alternative solutions, may limit market penetration and revenue potential. Furthermore, concerns regarding intellectual property and possible dilution add to the uncertainties facing Absci, negatively impacting investor confidence and outlook.

Absci Corp (ABSI) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Absci Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Absci Corp (ABSI) Forecast

Analysts have given Absci Corp (ABSI) a Buy based on their latest research and market trends.

According to 4 analysts, Absci Corp (ABSI) has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Absci Corp (ABSI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.